Frequencies for first 10,000 rows of indi_pt variable in indi2004q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL ABSCESS | 1 0.01 0.01 ABDOMINAL DISCOMFORT | 1 0.01 0.02 ABDOMINAL DISTENSION | 2 0.02 0.04 ABDOMINAL INFECTION | 4 0.04 0.08 ABDOMINAL PAIN | 6 0.06 0.14 ABDOMINAL PAIN UPPER | 5 0.05 0.19 ABNORMAL BEHAVIOUR | 8 0.08 0.27 ABORTION INDUCED | 1 0.01 0.28 ABSCESS | 3 0.03 0.31 ABSCESS INTESTINAL | 2 0.02 0.33 ACARODERMATITIS | 1 0.01 0.34 ACCIDENTAL EXPOSURE | 1 0.01 0.35 ACCIDENTAL NEEDLE STICK | 2 0.02 0.37 ACNE | 23 0.23 0.60 ACQUIRED IMMUNODEFICIENCY SYNDROME | 4 0.04 0.64 ACUTE CORONARY SYNDROME | 2 0.02 0.66 ACUTE ENDOCARDITIS | 2 0.02 0.68 ACUTE LYMPHOCYTIC LEUKAEMIA | 51 0.51 1.19 ACUTE MYELOID LEUKAEMIA | 46 0.46 1.65 ACUTE MYOCARDIAL INFARCTION | 22 0.22 1.87 ACUTE PROMYELOCYTIC LEUKAEMIA | 3 0.03 1.90 ACUTE RESPIRATORY DISTRESS SYNDROME | 1 0.01 1.91 ACUTE SINUSITIS | 1 0.01 1.92 ACUTE TONSILLITIS | 5 0.05 1.97 ADENOCARCINOMA | 7 0.07 2.04 ADENOCARCINOMA PANCREAS | 3 0.03 2.07 ADENOSQUAMOUS CARCINOMA OF THE CERVIX | 2 0.02 2.09 ADJUSTMENT DISORDER | 2 0.02 2.11 ADVERSE EVENT | 1 0.01 2.12 AFFECT LABILITY | 1 0.01 2.13 AFFECTIVE DISORDER | 3 0.03 2.16 AGE INDETERMINATE MYOCARDIAL INFARCTION | 3 0.03 2.19 AGGRESSION | 4 0.04 2.23 AGITATION | 9 0.09 2.32 AGORAPHOBIA | 2 0.02 2.34 ALCOHOLISM | 1 0.01 2.35 ALLOGENIC BONE MARROW TRANSPLANTATION.. | 2 0.02 2.37 ALOPECIA | 6 0.06 2.43 ANAEMIA | 13 0.13 2.56 ANAEMIA OF MALIGNANT DISEASE | 8 0.08 2.64 ANAESTHESIA | 18 0.18 2.82 ANAL CANCER | 1 0.01 2.83 ANAL FISTULA | 2 0.02 2.85 ANALGESIC EFFECT | 8 0.08 2.93 ANAPLASTIC ASTROCYTOMA | 2 0.02 2.95 ANDROGEN REPLACEMENT THERAPY | 1 0.01 2.96 ANGER | 3 0.03 2.99 ANGINA PECTORIS | 22 0.22 3.21 ANGIOGRAM | 2 0.02 3.23 ANGIOGRAM RETINA | 3 0.03 3.26 ANGIOSARCOMA | 2 0.02 3.28 ANGLE CLOSURE GLAUCOMA | 1 0.01 3.29 ANKYLOSING SPONDYLITIS | 18 0.18 3.47 ANOREXIA | 1 0.01 3.48 ANTICOAGULANT THERAPY | 11 0.11 3.59 ANTICOAGULATION DRUG LEVEL | 1 0.01 3.60 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.61 ANTIFUNGAL PROPHYLAXIS | 8 0.08 3.69 ANTIINFLAMMATORY THERAPY | 1 0.01 3.70 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 3.71 ANTIPLATELET THERAPY | 4 0.04 3.75 ANTIPYRESIS | 1 0.01 3.76 ANTIVIRAL PROPHYLAXIS | 13 0.13 3.89 ANXIETY | 73 0.73 4.62 ANXIETY DISORDER | 4 0.04 4.66 AORTIC ANEURYSM | 2 0.02 4.68 AORTIC VALVE STENOSIS | 1 0.01 4.69 APLASIA PURE RED CELL | 2 0.02 4.71 APNOEA | 1 0.01 4.72 APPENDICITIS | 1 0.01 4.73 APRAXIA | 1 0.01 4.74 ARRHYTHMIA | 19 0.19 4.93 ARRHYTHMIA SUPRAVENTRICULAR | 3 0.03 4.96 ARTERIAL BYPASS OPERATION | 1 0.01 4.97 ARTERIOPATHIC DISEASE | 1 0.01 4.98 ARTERIOSPASM CORONARY | 1 0.01 4.99 ARTERITIS | 6 0.06 5.05 ARTHRALGIA | 61 0.61 5.66 ARTHRITIS | 47 0.47 6.13 ARTHRITIS BACTERIAL | 1 0.01 6.14 ARTHRITIS REACTIVE | 1 0.01 6.15 ARTHROPATHY | 6 0.06 6.21 ASCITES | 9 0.09 6.30 ASPERGER'S DISORDER | 1 0.01 6.31 ASPERGILLOSIS | 4 0.04 6.35 ASPIRATION | 1 0.01 6.36 ASTHMA | 309 3.09 9.45 ATHEROSCLEROSIS OBLITERANS | 4 0.04 9.49 ATRIAL FIBRILLATION | 75 0.75 10.24 ATRIAL FLUTTER | 7 0.07 10.31 ATRIAL TACHYCARDIA | 2 0.02 10.33 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 43 0.43 10.76 AUTISM | 1 0.01 10.77 AUTOIMMUNE DISORDER | 2 0.02 10.79 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 4 0.04 10.83 B-CELL LYMPHOMA | 1 0.01 10.84 BACK INJURY | 2 0.02 10.86 BACK PAIN | 71 0.71 11.57 BACTERAEMIA | 2 0.02 11.59 BACTERIAL INFECTION | 7 0.07 11.66 BARRETT'S OESOPHAGUS | 2 0.02 11.68 BARTTER'S SYNDROME | 1 0.01 11.69 BASAL GANGLION DEGENERATION | 1 0.01 11.70 BASEDOW'S DISEASE | 3 0.03 11.73 BEHCET'S SYNDROME | 2 0.02 11.75 BENIGN NEOPLASM OF PROSTATE | 1 0.01 11.76 BENIGN PROSTATIC HYPERPLASIA | 21 0.21 11.97 BILE DUCT CANCER | 2 0.02 11.99 BINGE EATING | 1 0.01 12.00 BIOPSY | 1 0.01 12.01 BIPOLAR DISORDER | 24 0.24 12.25 BIPOLAR I DISORDER | 18 0.18 12.43 BLADDER CANCER | 19 0.19 12.62 BLADDER DISORDER | 3 0.03 12.65 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 2 0.02 12.67 BLINDNESS | 1 0.01 12.68 BLOOD CHOLESTEROL | 5 0.05 12.73 BLOOD CHOLESTEROL DECREASED | 1 0.01 12.74 BLOOD CHOLESTEROL INCREASED | 40 0.40 13.14 BLOOD GLUCOSE | 1 0.01 13.15 BLOOD PHOSPHORUS INCREASED | 1 0.01 13.16 BLOOD POTASSIUM INCREASED | 1 0.01 13.17 BLOOD PRESSURE | 22 0.22 13.39 BLOOD PRESSURE FLUCTUATION | 1 0.01 13.40 BLOOD PRESSURE INADEQUATELY CONTROLLED | 1 0.01 13.41 BLOOD PRESSURE INCREASED | 2 0.02 13.43 BLOOD TRIGLYCERIDES | 1 0.01 13.44 BLOOD TRIGLYCERIDES INCREASED | 2 0.02 13.46 BLOOD URIC ACID INCREASED | 1 0.01 13.47 BODY HEIGHT BELOW NORMAL | 2 0.02 13.49 BONE DISORDER | 4 0.04 13.53 BONE INFECTION | 2 0.02 13.55 BONE MARROW CONDITIONING REGIMEN | 2 0.02 13.57 BONE MARROW DEPRESSION | 1 0.01 13.58 BONE MARROW DISORDER | 4 0.04 13.62 BONE MARROW TOXICITY | 1 0.01 13.63 BONE MARROW TRANSPLANT | 51 0.51 14.14 BONE OPERATION | 1 0.01 14.15 BONE PAIN | 11 0.11 14.26 BONE SARCOMA | 6 0.06 14.32 BORDERLINE PERSONALITY DISORDER | 1 0.01 14.33 BORRELIA BURGDORFERI SEROLOGY POSITIVE | 1 0.01 14.34 BRAIN ABSCESS | 1 0.01 14.35 BRAIN MASS | 1 0.01 14.36 BRAIN NEOPLASM | 1 0.01 14.37 BRAIN NEOPLASM MALIGNANT | 5 0.05 14.42 BRAIN OEDEMA | 1 0.01 14.43 BREAST CANCER | 138 1.38 15.81 BREAST CANCER FEMALE | 3 0.03 15.84 BREAST CANCER METASTATIC | 37 0.37 16.21 BREAST CANCER RECURRENT | 3 0.03 16.24 BREAST CANCER STAGE II | 5 0.05 16.29 BREAST DISORDER | 1 0.01 16.30 BRONCHIAL CARCINOMA | 1 0.01 16.31 BRONCHIAL HYPERACTIVITY | 1 0.01 16.32 BRONCHIAL OBSTRUCTION | 1 0.01 16.33 BRONCHIOLITIS | 1 0.01 16.34 BRONCHITIS | 44 0.44 16.78 BRONCHITIS ACUTE | 7 0.07 16.85 BRONCHITIS CHRONIC | 1 0.01 16.86 BRONCHOPNEUMONIA | 2 0.02 16.88 BRONCHOPULMONARY ASPERGILLOSIS | 5 0.05 16.93 BRONCHOSPASM | 2 0.02 16.95 BURKITT'S LYMPHOMA | 7 0.07 17.02 BURSITIS | 2 0.02 17.04 CACHEXIA | 2 0.02 17.06 CANCER PAIN | 38 0.38 17.44 CANDIDIASIS | 11 0.11 17.55 CARCINOMA | 21 0.21 17.76 CARDIAC DISORDER | 14 0.14 17.90 CARDIAC FAILURE | 14 0.14 18.04 CARDIAC FAILURE CHRONIC | 6 0.06 18.10 CARDIAC FAILURE CONGESTIVE | 20 0.20 18.30 CARDIAC FIBRILLATION | 2 0.02 18.32 CARDIAC IMAGING PROCEDURE | 1 0.01 18.33 CARDIAC OPERATION | 3 0.03 18.36 CARDIAC VALVE DISEASE | 1 0.01 18.37 CARDIOMYOPATHY | 3 0.03 18.40 CARDIOVASCULAR DISORDER | 1 0.01 18.41 CARDIOVERSION | 1 0.01 18.42 CATARACT OPERATION | 1 0.01 18.43 CATHETER RELATED INFECTION | 1 0.01 18.44 CATHETERISATION CARDIAC | 1 0.01 18.45 CELLULITIS | 7 0.07 18.52 CENTRAL NERVOUS SYSTEM LYMPHOMA | 1 0.01 18.53 CENTRAL VENOUS CATHETERISATION | 1 0.01 18.54 CEREBELLAR INFARCTION | 1 0.01 18.55 CEREBRAL ATHEROSCLEROSIS | 1 0.01 18.56 CEREBRAL FUNGAL INFECTION | 2 0.02 18.58 CEREBRAL INFARCTION | 13 0.13 18.71 CEREBRAL PALSY | 2 0.02 18.73 CEREBROSPINAL FLUID RHINORRHOEA | 1 0.01 18.74 CEREBROVASCULAR ACCIDENT | 18 0.18 18.92 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 6 0.06 18.98 CEREBROVASCULAR SPASM | 1 0.01 18.99 CERVICAL ROOT PAIN | 4 0.04 19.03 CERVICOBRACHIAL SYNDROME | 1 0.01 19.04 CERVIX CANCER METASTATIC | 4 0.04 19.08 CERVIX CARCINOMA | 7 0.07 19.15 CHEMOTHERAPY | 30 0.30 19.45 CHEST PAIN | 4 0.04 19.49 CHEST WALL PAIN | 2 0.02 19.51 CHOLECYSTECTOMY | 2 0.02 19.53 CHONDRITIS | 1 0.01 19.54 CHOROIDAL NEOVASCULARISATION | 3 0.03 19.57 CHRONIC HEPATITIS | 4 0.04 19.61 CHRONIC LYMPHOCYTIC LEUKAEMIA | 5 0.05 19.66 CHRONIC MYELOID LEUKAEMIA | 24 0.24 19.90 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE | 44 0.44 20.34 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 2 0.02 20.36 CHRONIC SINUSITIS | 2 0.02 20.38 CIRRHOSIS ALCOHOLIC | 2 0.02 20.40 CLOSTRIDIUM COLITIS | 2 0.02 20.42 COAGULOPATHY | 7 0.07 20.49 COGNITIVE DISORDER | 1 0.01 20.50 COHEN SYNDROME | 1 0.01 20.51 COLITIS | 1 0.01 20.52 COLITIS ISCHAEMIC | 1 0.01 20.53 COLITIS ULCERATIVE | 12 0.12 20.65 COLON CANCER | 27 0.27 20.92 COLON CANCER METASTATIC | 4 0.04 20.96 COLON CANCER RECURRENT | 2 0.02 20.98 COLON CANCER STAGE III | 2 0.02 21.00 COLON CANCER STAGE IV | 1 0.01 21.01 COLONOSCOPY | 4 0.04 21.05 COLORECTAL CANCER | 56 0.56 21.61 COLORECTAL CANCER METASTATIC | 32 0.32 21.93 COLORECTAL CANCER STAGE III | 1 0.01 21.94 COMPLEX PARTIAL SEIZURES | 2 0.02 21.96 COMPRESSION FRACTURE | 1 0.01 21.97 COMPUTERISED TOMOGRAM | 5 0.05 22.02 CONCUSSION | 1 0.01 22.03 CONFUSIONAL STATE | 1 0.01 22.04 CONGENITAL PULMONARY HYPERTENSION | 2 0.02 22.06 CONGESTIVE CARDIOMYOPATHY | 2 0.02 22.08 CONJUNCTIVITIS | 4 0.04 22.12 CONJUNCTIVITIS ALLERGIC | 1 0.01 22.13 CONNECTIVE TISSUE DISORDER | 1 0.01 22.14 CONSTIPATION | 27 0.27 22.41 CONTRACEPTION | 42 0.42 22.83 CONTRACEPTIVE CAP | 2 0.02 22.85 CONTUSION | 1 0.01 22.86 CONVULSION | 69 0.69 23.55 CONVULSION NEONATAL | 5 0.05 23.60 CONVULSION PROPHYLAXIS | 3 0.03 23.63 CORONARY ANGIOPLASTY | 9 0.09 23.72 CORONARY ARTERY DISEASE | 21 0.21 23.93 CORONARY ARTERY STENOSIS | 1 0.01 23.94 CORONARY ARTERY SURGERY | 2 0.02 23.96 CORRECTIVE LENS USER | 1 0.01 23.97 COUGH | 19 0.19 24.16 CROHN'S DISEASE | 61 0.61 24.77 CUTANEOUS LUPUS ERYTHEMATOSUS | 2 0.02 24.79 CYCLOTHYMIC DISORDER | 4 0.04 24.83 CYSTIC FIBROSIS | 1 0.01 24.84 CYSTITIS | 8 0.08 24.92 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 24.93 CYTOMEGALOVIRUS INFECTION | 1 0.01 24.94 DEEP VEIN THROMBOSIS | 19 0.19 25.13 DEEP VENOUS THROMBOSIS PROPHYLAXIS | 6 0.06 25.19 DEFICIENCY ANAEMIA | 3 0.03 25.22 DELIRIUM | 3 0.03 25.25 DELUSION | 1 0.01 25.26 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 25.27 DELUSIONAL DISORDER, UNSPECIFIED TYPE | 2 0.02 25.29 DEMENTIA | 33 0.33 25.62 DEMENTIA ALZHEIMER'S TYPE | 83 0.83 26.45 DENTAL CARE | 1 0.01 26.46 DENTAL DISORDER PROPHYLAXIS | 1 0.01 26.47 DEPRESSED MOOD | 1 0.01 26.48 DEPRESSION | 311 3.11 29.59 DERMATITIS ATOPIC | 4 0.04 29.63 DERMATITIS CONTACT | 2 0.02 29.65 DERMATOMYOSITIS | 2 0.02 29.67 DIABETES INSIPIDUS | 4 0.04 29.71 DIABETES MELLITUS | 170 1.70 31.41 DIABETES MELLITUS INSULIN-DEPENDENT | 42 0.42 31.83 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 92 0.92 32.75 DIABETIC GASTROPARESIS | 2 0.02 32.77 DIABETIC NEPHROPATHY | 3 0.03 32.80 DIABETIC NEUROPATHY | 2 0.02 32.82 DIABETIC RETINOPATHY | 3 0.03 32.85 DIAGNOSTIC PROCEDURE | 1 0.01 32.86 DIALYSIS | 3 0.03 32.89 DIAPHRAGMATIC HERNIA | 2 0.02 32.91 DIARRHOEA | 9 0.09 33.00 DIFFUSE LARGE B-CELL LYMPHOMA | 4 0.04 33.04 DISCOMFORT | 1 0.01 33.05 DISEASE RECURRENCE | 4 0.04 33.09 DISSEMINATED INTRAVASCULAR COAGULATION | 1 0.01 33.10 DISTURBANCE IN ATTENTION | 1 0.01 33.11 DISTURBANCE IN SOCIAL BEHAVIOUR | 1 0.01 33.12 DIZZINESS | 1 0.01 33.13 DRUG ABUSER | 3 0.03 33.16 DRUG DEPENDENCE | 6 0.06 33.22 DRUG EXPOSURE DURING PREGNANCY | 2 0.02 33.24 DRUG TOXICITY | 1 0.01 33.25 DRUG USE FOR UNKNOWN INDICATION | 302 3.02 36.27 DRUG WITHDRAWAL SYNDROME | 1 0.01 36.28 DUODENAL ULCER | 5 0.05 36.33 DUODENAL ULCER HAEMORRHAGE | 2 0.02 36.35 DYSLIPIDAEMIA | 12 0.12 36.47 DYSMENORRHOEA | 4 0.04 36.51 DYSPEPSIA | 12 0.12 36.63 DYSPHAGIA | 1 0.01 36.64 DYSPNOEA | 4 0.04 36.68 DYSTHYMIC DISORDER | 9 0.09 36.77 DYSTONIA | 2 0.02 36.79 DYSURIA | 1 0.01 36.80 EAR INFECTION | 4 0.04 36.84 ECHINOCOCCIASIS | 1 0.01 36.85 ECHOCARDIOGRAM | 1 0.01 36.86 ECZEMA | 4 0.04 36.90 ECZEMA INFECTED | 2 0.02 36.92 ELECTROLYTE SUBSTITUTION THERAPY | 1 0.01 36.93 EMBOLIC STROKE | 1 0.01 36.94 EMPHYSEMA | 10 0.10 37.04 ENCEPHALITIS HERPES | 2 0.02 37.06 ENCEPHALOPATHY | 1 0.01 37.07 ENDOCARDITIS | 2 0.02 37.09 ENDOMETRIAL CANCER | 3 0.03 37.12 ENDOMETRIAL HYPERPLASIA | 1 0.01 37.13 ENDOMETRIOSIS | 1 0.01 37.14 ENDOPHTHALMITIS | 2 0.02 37.16 ENURESIS | 3 0.03 37.19 EOSINOPHILIA | 1 0.01 37.20 EPIDURAL ANAESTHESIA | 11 0.11 37.31 EPILEPSY | 92 0.92 38.23 ERECTILE DYSFUNCTION | 31 0.31 38.54 ESCHERICHIA INFECTION | 2 0.02 38.56 ESSENTIAL HYPERTENSION | 29 0.29 38.85 ESSENTIAL THROMBOCYTHAEMIA | 3 0.03 38.88 ESSENTIAL TREMOR | 1 0.01 38.89 EUPHORIC MOOD | 2 0.02 38.91 EWING'S SARCOMA | 3 0.03 38.94 EX-SMOKER | 25 0.25 39.19 EXCORIATION | 1 0.01 39.20 EXOSTOSIS | 4 0.04 39.24 EXTRADURAL ABSCESS | 1 0.01 39.25 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 1 0.01 39.26 EXTRASYSTOLES | 1 0.01 39.27 EYE PRURITUS | 3 0.03 39.30 FABRY'S DISEASE | 3 0.03 39.33 FACTOR VIII DEFICIENCY | 1 0.01 39.34 FALLOPIAN TUBE CANCER | 2 0.02 39.36 FAMILIAL MEDITERRANEAN FEVER | 1 0.01 39.37 FATIGUE | 6 0.06 39.43 FEBRILE CONVULSION | 1 0.01 39.44 FEBRILE NEUTROPENIA | 5 0.05 39.49 FIBROMYALGIA | 14 0.14 39.63 FLANK PAIN | 1 0.01 39.64 FLATULENCE | 2 0.02 39.66 FLUID REPLACEMENT | 1 0.01 39.67 FLUID RETENTION | 5 0.05 39.72 FOLLICULITIS | 1 0.01 39.73 FRACTURE | 1 0.01 39.74 FULGURATION | 1 0.01 39.75 FUNGAEMIA | 1 0.01 39.76 FUNGAL INFECTION | 7 0.07 39.83 FUNGAL SEPSIS | 1 0.01 39.84 FUNGAL SKIN INFECTION | 2 0.02 39.86 GALLBLADDER CANCER | 1 0.01 39.87 GANGRENE | 1 0.01 39.88 GASTRIC CANCER | 20 0.20 40.08 GASTRIC CANCER STAGE IV WITH METASTASES | 1 0.01 40.09 GASTRIC DISORDER | 4 0.04 40.13 GASTRIC ULCER | 25 0.25 40.38 GASTRIC ULCER HAEMORRHAGE | 1 0.01 40.39 GASTRITIS | 29 0.29 40.68 GASTRITIS EROSIVE | 3 0.03 40.71 GASTROENTERITIS | 3 0.03 40.74 GASTROINTESTINAL DISORDER | 3 0.03 40.77 GASTROINTESTINAL HAEMORRHAGE | 5 0.05 40.82 GASTROINTESTINAL MOTILITY DISORDER | 3 0.03 40.85 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 40.86 GASTROINTESTINAL STROMAL TUMOUR | 15 0.15 41.01 GASTROOESOPHAGEAL REFLUX DISEASE | 40 0.40 41.41 GAUCHER'S DISEASE | 9 0.09 41.50 GENERAL ANAESTHESIA | 4 0.04 41.54 GENERAL SYMPTOM | 4 0.04 41.58 GENERALISED ANXIETY DISORDER | 4 0.04 41.62 GESTATIONAL DIABETES | 1 0.01 41.63 GINGIVAL INFECTION | 1 0.01 41.64 GLAUCOMA | 15 0.15 41.79 GLIOBLASTOMA | 5 0.05 41.84 GLIOBLASTOMA MULTIFORME | 3 0.03 41.87 GLIOMA | 1 0.01 41.88 GLOMERULONEPHRITIS PROLIFERATIVE | 4 0.04 41.92 GLYCOPEPTIDE ANTIBIOTIC RESISTANT ENT.. | 1 0.01 41.93 GOUT | 13 0.13 42.06 GRAFT INFECTION | 1 0.01 42.07 GRAFT VERSUS HOST DISEASE | 5 0.05 42.12 GRAND MAL CONVULSION | 5 0.05 42.17 GROWTH HORMONE DEFICIENCY | 5 0.05 42.22 HAEMANGIOMA | 4 0.04 42.26 HAEMODIALYSIS | 6 0.06 42.32 HAEMOPTYSIS | 2 0.02 42.34 HAEMORRHAGE | 2 0.02 42.36 HAEMORRHOIDS | 1 0.01 42.37 HAEMOSIDEROSIS | 1 0.01 42.38 HAEMOTHORAX | 1 0.01 42.39 HAIRY CELL LEUKAEMIA | 1 0.01 42.40 HALLUCINATION | 1 0.01 42.41 HEADACHE | 12 0.12 42.53 HEART RATE ABNORMAL | 1 0.01 42.54 HEART RATE IRREGULAR | 1 0.01 42.55 HEART TRANSPLANT | 7 0.07 42.62 HEART VALVE REPLACEMENT | 1 0.01 42.63 HELICOBACTER INFECTION | 6 0.06 42.69 HELMINTHIC INFECTION | 3 0.03 42.72 HEMIPLEGIA | 12 0.12 42.84 HEPATIC CYST | 1 0.01 42.85 HEPATIC NEOPLASM MALIGNANT | 2 0.02 42.87 HEPATIC STEATOSIS | 1 0.01 42.88 HEPATITIS | 12 0.12 43.00 HEPATITIS B | 2 0.02 43.02 HEPATITIS C | 136 1.36 44.38 HERNIA | 1 0.01 44.39 HERPES SIMPLEX | 4 0.04 44.43 HERPES VIRUS INFECTION | 2 0.02 44.45 HERPES ZOSTER | 27 0.27 44.72 HERPES ZOSTER INFECTION NEUROLOGICAL | 1 0.01 44.73 HIATUS HERNIA | 5 0.05 44.78 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 44.79 HIP ARTHROPLASTY | 5 0.05 44.84 HIP FRACTURE | 1 0.01 44.85 HIV INFECTION | 369 3.69 48.54 HIV TEST | 4 0.04 48.58 HIV TEST POSITIVE | 1 0.01 48.59 HODGKIN'S DISEASE | 9 0.09 48.68 HORMONE REPLACEMENT THERAPY | 62 0.62 49.30 HOT FLUSH | 1 0.01 49.31 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 20 0.20 49.51 HUNTINGTON'S CHOREA | 1 0.01 49.52 HYPERADRENOCORTICISM | 2 0.02 49.54 HYPERCALCAEMIA | 3 0.03 49.57 HYPERCALCAEMIA OF MALIGNANCY | 5 0.05 49.62 HYPERCHLORHYDRIA | 1 0.01 49.63 HYPERCHOLESTEROLAEMIA | 86 0.86 50.49 HYPERGLYCAEMIA | 1 0.01 50.50 HYPERHOMOCYSTEINAEMIA | 2 0.02 50.52 HYPERKALAEMIA | 1 0.01 50.53 HYPERLIPIDAEMIA | 49 0.49 51.02 HYPERPARATHYROIDISM SECONDARY | 6 0.06 51.08 HYPERPHOSPHATAEMIA | 17 0.17 51.25 HYPERPROLACTINAEMIA | 3 0.03 51.28 HYPERSENSITIVITY | 28 0.28 51.56 HYPERSOMNIA | 1 0.01 51.57 HYPERTENSION | 427 4.27 55.84 HYPERTENSIVE CARDIOMYOPATHY | 5 0.05 55.89 HYPERTENSIVE EMERGENCY | 3 0.03 55.92 HYPERTHERMIA | 2 0.02 55.94 HYPERTHYROIDISM | 2 0.02 55.96 HYPERURICAEMIA | 10 0.10 56.06 HYPOAESTHESIA | 1 0.01 56.07 HYPOGLYCAEMIA | 1 0.01 56.08 HYPOGONADISM | 2 0.02 56.10 HYPOGONADISM MALE | 1 0.01 56.11 HYPOKALAEMIA | 3 0.03 56.14 HYPOMANIA | 2 0.02 56.16 HYPONATRAEMIA | 1 0.01 56.17 HYPOPITUITARISM | 12 0.12 56.29 HYPOPLASTIC LEFT HEART SYNDROME | 1 0.01 56.30 HYPOTHYROIDISM | 23 0.23 56.53 HYPOTONIA | 1 0.01 56.54 HYPOTRICHOSIS | 1 0.01 56.55 HYPOVITAMINOSIS | 1 0.01 56.56 HYSTERECTOMY | 3 0.03 56.59 HYSTEROSALPINGO-OOPHORECTOMY | 2 0.02 56.61 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 5 0.05 56.66 ILL-DEFINED DISORDER | 292 2.92 59.58 IMMUNODEFICIENCY | 1 0.01 59.59 IMMUNOSUPPRESSANT DRUG THERAPY | 5 0.05 59.64 IMMUNOSUPPRESSION | 7 0.07 59.71 IMPAIRED GASTRIC EMPTYING | 16 0.16 59.87 INCONTINENCE | 1 0.01 59.88 INCREASED APPETITE | 1 0.01 59.89 INCREASED UPPER AIRWAY SECRETION | 1 0.01 59.90 INDUCED LABOUR | 3 0.03 59.93 INDUCTION OF ANAESTHESIA | 1 0.01 59.94 INFANTILE SPASMS | 1 0.01 59.95 INFARCTION | 1 0.01 59.96 INFECTED SEBACEOUS CYST | 1 0.01 59.97 INFECTION | 19 0.19 60.16 INFECTION PARASITIC | 4 0.04 60.20 INFECTION PROPHYLAXIS | 13 0.13 60.33 INFERTILITY | 2 0.02 60.35 INFILTRATION ANAESTHESIA | 1 0.01 60.36 INFLAMMATION | 12 0.12 60.48 INFLAMMATORY BOWEL DISEASE | 1 0.01 60.49 INFLUENZA | 4 0.04 60.53 INFLUENZA LIKE ILLNESS | 2 0.02 60.55 INNER EAR DISORDER | 1 0.01 60.56 INSOMNIA | 46 0.46 61.02 INSULIN-REQUIRING TYPE II DIABETES ME.. | 8 0.08 61.10 INTENSIVE CARE | 1 0.01 61.11 INTENTIONAL MISUSE | 1 0.01 61.12 INTENTIONAL OVERDOSE | 1 0.01 61.13 INTERMITTENT CLAUDICATION | 8 0.08 61.21 INTERSTITIAL LUNG DISEASE | 4 0.04 61.25 INTERVERTEBRAL DISC DEGENERATION | 4 0.04 61.29 INTERVERTEBRAL DISC DISORDER | 2 0.02 61.31 INTERVERTEBRAL DISC DISPLACEMENT | 1 0.01 61.32 INTERVERTEBRAL DISC PROTRUSION | 2 0.02 61.34 INTESTINAL PERFORATION | 1 0.01 61.35 INTRACARDIAC THROMBUS | 1 0.01 61.36 INTUBATION | 1 0.01 61.37 INVESTIGATION | 1 0.01 61.38 IRRITABILITY | 5 0.05 61.43 IRRITABLE BOWEL SYNDROME | 30 0.30 61.73 ISCHAEMIC CARDIOMYOPATHY | 4 0.04 61.77 ISCHAEMIC STROKE | 2 0.02 61.79 JOINT ARTHROPLASTY | 1 0.01 61.80 JOINT DISLOCATION | 1 0.01 61.81 JOINT INJURY | 3 0.03 61.84 JOINT SPRAIN | 1 0.01 61.85 JOINT STIFFNESS | 2 0.02 61.87 JOINT SWELLING | 1 0.01 61.88 JUVENILE ARTHRITIS | 6 0.06 61.94 KIDNEY TRANSPLANT REJECTION | 2 0.02 61.96 KNEE ARTHROPLASTY | 5 0.05 62.01 KNEE OPERATION | 1 0.01 62.02 LABORATORY TEST ABNORMAL | 1 0.01 62.03 LABOUR INDUCTION | 2 0.02 62.05 LACUNAR INFARCTION | 1 0.01 62.06 LARGE CELL CARCINOMA OF THE RESPIRATO.. | 1 0.01 62.07 LARYNGEAL CANCER | 8 0.08 62.15 LARYNGOSPASM | 1 0.01 62.16 LAXATIVE SUPPORTIVE CARE | 1 0.01 62.17 LEUKAEMIA | 7 0.07 62.24 LICE INFESTATION | 6 0.06 62.30 LIGAMENT INJURY | 1 0.01 62.31 LIMB DISCOMFORT | 1 0.01 62.32 LIMB INJURY | 2 0.02 62.34 LIMB OPERATION | 2 0.02 62.36 LIPID METABOLISM DISORDER | 1 0.01 62.37 LIPIDS ABNORMAL | 3 0.03 62.40 LIVER DISORDER | 2 0.02 62.42 LIVER FUNCTION TEST ABNORMAL | 2 0.02 62.44 LIVER TRANSPLANT | 15 0.15 62.59 LOCAL ANAESTHESIA | 7 0.07 62.66 LOCALISED OSTEOARTHRITIS | 31 0.31 62.97 LOOSE STOOLS | 2 0.02 62.99 LOW DENSITY LIPOPROTEIN INCREASED | 3 0.03 63.02 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 63.04 LUMBAR PUNCTURE HEADACHE | 2 0.02 63.06 LUMBAR SPINAL STENOSIS | 1 0.01 63.07 LUMBAR VERTEBRAL FRACTURE | 1 0.01 63.08 LUNG ADENOCARCINOMA | 16 0.16 63.24 LUNG CANCER METASTATIC | 4 0.04 63.28 LUNG DISORDER | 12 0.12 63.40 LUNG INFECTION | 10 0.10 63.50 LUNG NEOPLASM MALIGNANT | 25 0.25 63.75 LUNG SQUAMOUS CELL CARCINOMA STAGE UN.. | 4 0.04 63.79 LUNG TRANSPLANT | 8 0.08 63.87 LYMPHANGITIS | 1 0.01 63.88 LYMPHOCYTIC LEUKAEMIA | 2 0.02 63.90 LYMPHOMA | 36 0.36 64.26 MACULAR DEGENERATION | 3 0.03 64.29 MACULAR OEDEMA | 1 0.01 64.30 MAINTENANCE OF ANAESTHESIA | 1 0.01 64.31 MAJOR DEPRESSION | 7 0.07 64.38 MALAISE | 2 0.02 64.40 MALARIA | 3 0.03 64.43 MALARIA PROPHYLAXIS | 10 0.10 64.53 MALE PATTERN BALDNESS | 3 0.03 64.56 MALIGNANT HAEMANGIOPERICYTOMA | 4 0.04 64.60 MALIGNANT MELANOMA | 10 0.10 64.70 MALIGNANT MELANOMA IN SITU | 1 0.01 64.71 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 64.72 MALIGNANT PERITONEAL NEOPLASM | 1 0.01 64.73 MANIA | 2 0.02 64.75 MANTLE CELL LYMPHOMA | 3 0.03 64.78 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 64.79 MEDIASTINITIS | 2 0.02 64.81 MEDICAL DIET | 1 0.01 64.82 MEDICATION ERROR | 1 0.01 64.83 MEDULLOBLASTOMA | 3 0.03 64.86 MEMORY IMPAIRMENT | 4 0.04 64.90 MENIERE'S DISEASE | 2 0.02 64.92 MENINGITIS | 3 0.03 64.95 MENISCUS LESION | 1 0.01 64.96 MENOMETRORRHAGIA | 1 0.01 64.97 MENOPAUSAL DISORDER | 1 0.01 64.98 MENOPAUSAL SYMPTOMS | 8 0.08 65.06 MENOPAUSE | 2 0.02 65.08 MENORRHAGIA | 5 0.05 65.13 MENSTRUAL DISORDER | 1 0.01 65.14 MENSTRUATION IRREGULAR | 1 0.01 65.15 MENTAL DISORDER | 3 0.03 65.18 MENTAL DISORDER DUE TO A GENERAL MEDI.. | 1 0.01 65.19 MENTAL IMPAIRMENT | 1 0.01 65.20 MERALGIA PARAESTHETICA | 2 0.02 65.22 MESENTERIC OCCLUSION | 1 0.01 65.23 MESOTHELIOMA | 8 0.08 65.31 MESOTHELIOMA MALIGNANT | 2 0.02 65.33 METASTASES TO BONE | 16 0.16 65.49 METASTASES TO CENTRAL NERVOUS SYSTEM | 6 0.06 65.55 METASTASES TO LIVER | 4 0.04 65.59 METASTASES TO LUNG | 1 0.01 65.60 METASTASES TO MENINGES | 1 0.01 65.61 METASTASIS | 1 0.01 65.62 METASTATIC MALIGNANT MELANOMA | 15 0.15 65.77 METASTATIC NEOPLASM | 7 0.07 65.84 METASTATIC RENAL CELL CARCINOMA | 3 0.03 65.87 MICTURITION URGENCY | 1 0.01 65.88 MIGRAINE | 33 0.33 66.21 MIGRAINE PROPHYLAXIS | 2 0.02 66.23 MINERAL SUPPLEMENTATION | 7 0.07 66.30 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 66.31 MONARTHRITIS | 2 0.02 66.33 MOOD ALTERED | 4 0.04 66.37 MOTION SICKNESS | 1 0.01 66.38 MOUTH CYST | 1 0.01 66.39 MUCOPOLYSACCHARIDOSIS IH | 1 0.01 66.40 MULTIPLE ALLERGIES | 4 0.04 66.44 MULTIPLE FRACTURES | 1 0.01 66.45 MULTIPLE MYELOMA | 79 0.79 67.24 MULTIPLE SCLEROSIS | 292 2.92 70.16 MULTIPLE SCLEROSIS RELAPSE | 4 0.04 70.20 MUSCLE CRAMP | 4 0.04 70.24 MUSCLE RELAXANT THERAPY | 1 0.01 70.25 MUSCLE SPASMS | 8 0.08 70.33 MUSCLE SPASTICITY | 6 0.06 70.39 MUSCLE STRAIN | 1 0.01 70.40 MUSCULOSKELETAL DISORDER | 3 0.03 70.43 MUSCULOSKELETAL PAIN | 4 0.04 70.47 MYALGIA | 4 0.04 70.51 MYASTHENIA GRAVIS | 2 0.02 70.53 MYCOBACTERIAL INFECTION | 1 0.01 70.54 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 70.55 MYCOSIS FUNGOIDES | 1 0.01 70.56 MYDRIASIS | 1 0.01 70.57 MYELODYSPLASTIC SYNDROME | 14 0.14 70.71 MYELOFIBROSIS | 2 0.02 70.73 MYELOID LEUKAEMIA | 4 0.04 70.77 MYOCARDIAL INFARCTION | 31 0.31 71.08 MYOCARDIAL ISCHAEMIA | 6 0.06 71.14 MYOSITIS | 3 0.03 71.17 NAIL TINEA | 18 0.18 71.35 NARCOLEPSY | 9 0.09 71.44 NASAL CONGESTION | 5 0.05 71.49 NASAL DECONGESTION THERAPY | 2 0.02 71.51 NASAL POLYPS | 1 0.01 71.52 NASOPHARYNGITIS | 30 0.30 71.82 NAUSEA | 15 0.15 71.97 NECK PAIN | 6 0.06 72.03 NEONATAL RESPIRATORY DISTRESS SYNDROME | 4 0.04 72.07 NEOPLASM | 1 0.01 72.08 NEOPLASM MALIGNANT | 6 0.06 72.14 NEOPLASM RECURRENCE | 8 0.08 72.22 NEPHROGENIC DIABETES INSIPIDUS | 5 0.05 72.27 NEPHROTIC SYNDROME | 2 0.02 72.29 NERVE BLOCK | 2 0.02 72.31 NERVE COMPRESSION | 1 0.01 72.32 NERVOUS SYSTEM DISORDER | 1 0.01 72.33 NERVOUSNESS | 3 0.03 72.36 NEURALGIA | 5 0.05 72.41 NEUROBLASTOMA | 5 0.05 72.46 NEURODERMATITIS | 1 0.01 72.47 NEUROGENIC BLADDER | 3 0.03 72.50 NEUROMUSCULAR BLOCKADE | 1 0.01 72.51 NEUROPATHIC PAIN | 8 0.08 72.59 NEUROPATHY | 6 0.06 72.65 NEUROPATHY PERIPHERAL | 2 0.02 72.67 NEUROSIS | 1 0.01 72.68 NEUROTOXICITY | 2 0.02 72.70 NEUTROPENIA | 3 0.03 72.73 NIGHT CRAMPS | 1 0.01 72.74 NOCTURIA | 1 0.01 72.75 NON-HODGKIN'S LYMPHOMA | 55 0.55 73.30 NON-HODGKIN'S LYMPHOMA STAGE III | 6 0.06 73.36 NON-SMALL CELL LUNG CANCER | 87 0.87 74.23 NON-SMALL CELL LUNG CANCER STAGE IV | 3 0.03 74.26 NORMAL PRESSURE HYDROCEPHALUS | 1 0.01 74.27 NUCLEAR MAGNETIC RESONANCE IMAGING | 4 0.04 74.31 NUTRITIONAL SUPPORT | 11 0.11 74.42 OBESITY | 7 0.07 74.49 OBSESSIVE THOUGHTS | 1 0.01 74.50 OBSESSIVE-COMPULSIVE DISORDER | 8 0.08 74.58 OCULAR HYPERTENSION | 3 0.03 74.61 ODYNOPHAGIA | 3 0.03 74.64 OEDEMA | 8 0.08 74.72 OEDEMA DUE TO CARDIAC DISEASE | 1 0.01 74.73 OEDEMA DUE TO RENAL DISEASE | 1 0.01 74.74 OEDEMA PERIPHERAL | 7 0.07 74.81 OESOPHAGEAL CANDIDIASIS | 1 0.01 74.82 OESOPHAGEAL CARCINOMA | 9 0.09 74.91 OESOPHAGEAL DISORDER | 1 0.01 74.92 OESOPHAGEAL ULCER | 1 0.01 74.93 OESOPHAGITIS | 3 0.03 74.96 OESTROGEN REPLACEMENT THERAPY | 1 0.01 74.97 OESTROGEN THERAPY | 1 0.01 74.98 OLIGODENDROGLIOMA | 4 0.04 75.02 OLIGURIA | 4 0.04 75.06 ONCHOCERCIASIS | 1 0.01 75.07 ONYCHOGRYPHOSIS | 1 0.01 75.08 ONYCHOMYCOSIS | 5 0.05 75.13 OOCYTE DONATION | 2 0.02 75.15 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 75.16 ORAL CANDIDIASIS | 7 0.07 75.23 ORAL CONTRACEPTION | 12 0.12 75.35 ORGAN FAILURE | 1 0.01 75.36 ORGANIC ERECTILE DYSFUNCTION | 2 0.02 75.38 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 75.39 ORTHOPEDIC PROCEDURE | 1 0.01 75.40 OSTEITIS DEFORMANS | 2 0.02 75.42 OSTEOARTHRITIS | 55 0.55 75.97 OSTEOLYSIS | 2 0.02 75.99 OSTEOMYELITIS | 5 0.05 76.04 OSTEOMYELITIS CHRONIC | 2 0.02 76.06 OSTEOPENIA | 5 0.05 76.11 OSTEOPOROSIS | 125 1.25 77.36 OSTEOPOROSIS POSTMENOPAUSAL | 7 0.07 77.43 OTITIS MEDIA | 2 0.02 77.45 OTITIS MEDIA ACUTE | 3 0.03 77.48 OVARIAN CANCER | 46 0.46 77.94 OVARIAN DISORDER | 1 0.01 77.95 OVERDOSE | 1 0.01 77.96 PAIN | 203 2.03 79.99 PAIN IN EXTREMITY | 17 0.17 80.16 PAIN IN JAW | 2 0.02 80.18 PAIN MANAGEMENT | 3 0.03 80.21 PAIN PROPHYLAXIS | 2 0.02 80.23 PAINFUL RESPIRATION | 1 0.01 80.24 PALPITATIONS | 1 0.01 80.25 PANCREATIC CARCINOMA | 37 0.37 80.62 PANCREATITIS ACUTE | 2 0.02 80.64 PANCREATITIS CHRONIC | 1 0.01 80.65 PANCYTOPENIA | 2 0.02 80.67 PANIC ATTACK | 6 0.06 80.73 PANIC DISORDER | 7 0.07 80.80 PAPILLOMA | 1 0.01 80.81 PARANOIA | 3 0.03 80.84 PARAPROTEINAEMIA | 1 0.01 80.85 PARKINSON'S DISEASE | 31 0.31 81.16 PARTIAL SEIZURES | 18 0.18 81.34 PATENT DUCTUS ARTERIOSUS | 15 0.15 81.49 PEPTIC ULCER | 1 0.01 81.50 PERIARTHRITIS | 3 0.03 81.53 PERIPHERAL ARTERY ANGIOPLASTY | 10 0.10 81.63 PERIPHERAL BLOOD STEM CELL APHERESIS | 2 0.02 81.65 PERIPHERAL EMBOLISM | 1 0.01 81.66 PERITONEAL CARCINOMA | 2 0.02 81.68 PERITONEAL DIALYSIS | 3 0.03 81.71 PERITONEAL MESOTHELIOMA MALIGNANT | 1 0.01 81.72 PERITONEAL TUBERCULOSIS | 3 0.03 81.75 PERITONITIS | 2 0.02 81.77 PERITONITIS BACTERIAL | 1 0.01 81.78 PERSONALITY DISORDER | 1 0.01 81.79 PERVASIVE DEVELOPMENTAL DISORDER | 1 0.01 81.80 PETIT MAL EPILEPSY | 1 0.01 81.81 PHANTOM PAIN | 1 0.01 81.82 PHARYNGEAL CANCER STAGE UNSPECIFIED | 2 0.02 81.84 PHARYNGITIS | 3 0.03 81.87 PHARYNGITIS STREPTOCOCCAL | 1 0.01 81.88 PHARYNGOLARYNGEAL PAIN | 2 0.02 81.90 PHARYNGOTONSILLITIS | 1 0.01 81.91 PHLEBITIS | 1 0.01 81.92 PHLEBOTHROMBOSIS | 1 0.01 81.93 PHOBIA | 1 0.01 81.94 PINEOCYTOMA | 1 0.01 81.95 PITUITARY TUMOUR | 2 0.02 81.97 PITUITARY TUMOUR BENIGN | 4 0.04 82.01 PLATELET AGGREGATION INHIBITION | 1 0.01 82.02 PLATELET COUNT INCREASED | 4 0.04 82.06 PNEUMOCOCCAL INFECTION | 1 0.01 82.07 PNEUMOCYSTIS CARINII INFECTION | 2 0.02 82.09 PNEUMOCYSTIS CARINII PNEUMONIA | 4 0.04 82.13 PNEUMONIA | 47 0.47 82.60 PNEUMONIA ASPIRATION | 1 0.01 82.61 PNEUMONIA MYCOPLASMAL | 1 0.01 82.62 PNEUMONIA STREPTOCOCCAL | 1 0.01 82.63 PNEUMONITIS | 3 0.03 82.66 POLLAKIURIA | 1 0.01 82.67 POLYARTERITIS NODOSA | 1 0.01 82.68 POLYARTHRITIS | 2 0.02 82.70 POLYCYTHAEMIA VERA | 2 0.02 82.72 POLYMYOSITIS | 3 0.03 82.75 POLYNEUROPATHY | 2 0.02 82.77 POST COITAL CONTRACEPTION | 1 0.01 82.78 POST HERPETIC NEURALGIA | 1 0.01 82.79 POST PROCEDURAL COMPLICATION | 1 0.01 82.80 POST PROCEDURAL NAUSEA | 2 0.02 82.82 POST PROCEDURAL PAIN | 2 0.02 82.84 POST PROCEDURAL VOMITING | 1 0.01 82.85 POST-TRAUMATIC EPILEPSY | 1 0.01 82.86 POST-TRAUMATIC STRESS DISORDER | 2 0.02 82.88 POSTNASAL DRIP | 1 0.01 82.89 POSTOPERATIVE ADHESION | 2 0.02 82.91 POSTOPERATIVE ANALGESIA | 1 0.01 82.92 POSTOPERATIVE CARE | 1 0.01 82.93 POSTOPERATIVE FEVER | 2 0.02 82.95 POSTPARTUM DEPRESSION | 2 0.02 82.97 PRADER-WILLI SYNDROME | 2 0.02 82.99 PRE-EXISTING DISEASE | 4 0.04 83.03 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA | 1 0.01 83.04 PREGNANCY | 5 0.05 83.09 PREMEDICATION | 25 0.25 83.34 PREMENSTRUAL SYNDROME | 4 0.04 83.38 PREOPERATIVE CARE | 10 0.10 83.48 PRIMITIVE NEUROECTODERMAL TUMOUR | 3 0.03 83.51 PRINZMETAL ANGINA | 1 0.01 83.52 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 83.53 PROPHYLAXIS | 79 0.79 84.32 PROPHYLAXIS AGAINST ALCOHOLIC WITHDRA.. | 1 0.01 84.33 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 5 0.05 84.38 PROPHYLAXIS AGAINST HIV INFECTION | 5 0.05 84.43 PROPHYLAXIS AGAINST MOTION SICKNESS | 1 0.01 84.44 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 38 0.38 84.82 PROPHYLAXIS OF NAUSEA AND VOMITING | 14 0.14 84.96 PROSTATE CANCER | 44 0.44 85.40 PROSTATE CANCER METASTATIC | 11 0.11 85.51 PROSTATE CANCER STAGE IV | 1 0.01 85.52 PROSTATISM | 1 0.01 85.53 PROSTATITIS | 2 0.02 85.55 PROTEIN C DECREASED | 2 0.02 85.57 PROTEIN S DECREASED | 2 0.02 85.59 PROTEINURIA | 1 0.01 85.60 PRURITUS | 6 0.06 85.66 PSEUDOMONAS INFECTION | 4 0.04 85.70 PSORIASIS | 34 0.34 86.04 PSORIATIC ARTHROPATHY | 29 0.29 86.33 PSYCHOMOTOR HYPERACTIVITY | 6 0.06 86.39 PSYCHOTIC DISORDER | 23 0.23 86.62 PULMONARY EMBOLISM | 4 0.04 86.66 PULMONARY FIBROSIS | 2 0.02 86.68 PULMONARY HYPERTENSION | 35 0.35 87.03 PULMONARY TUBERCULOSIS | 4 0.04 87.07 PURPURA | 1 0.01 87.08 PYELONEPHRITIS | 3 0.03 87.11 PYELONEPHRITIS ACUTE | 2 0.02 87.13 PYODERMA GANGRENOSUM | 1 0.01 87.14 PYREXIA | 29 0.29 87.43 RADICULITIS LUMBOSACRAL | 1 0.01 87.44 RADICULOPATHY | 1 0.01 87.45 RADIOTHERAPY TO BRAIN | 1 0.01 87.46 RASH | 2 0.02 87.48 RAYNAUD'S PHENOMENON | 1 0.01 87.49 RECTAL CANCER | 7 0.07 87.56 RECTAL CANCER METASTATIC | 4 0.04 87.60 RECURRENT CANCER | 4 0.04 87.64 REFLEX SYMPATHETIC DYSTROPHY | 1 0.01 87.65 REFLUX OESOPHAGITIS | 6 0.06 87.71 RENAL AND PANCREAS TRANSPLANT | 1 0.01 87.72 RENAL AND PANCREAS TRANSPLANT REJECTION | 1 0.01 87.73 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 15 0.15 87.88 RENAL DISORDER | 2 0.02 87.90 RENAL FAILURE ACUTE | 1 0.01 87.91 RENAL FAILURE CHRONIC | 11 0.11 88.02 RENAL TRANSPLANT | 46 0.46 88.48 RESPIRATORY DISORDER | 3 0.03 88.51 RESPIRATORY FAILURE | 1 0.01 88.52 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2 0.02 88.54 RESPIRATORY TRACT INFECTION | 3 0.03 88.57 RESPIRATORY TRACT INFECTION FUNGAL | 1 0.01 88.58 RESTLESSNESS | 2 0.02 88.60 RETROVIRAL INFECTION | 16 0.16 88.76 REVERSIBLE AIRWAYS OBSTRUCTION | 1 0.01 88.77 RHABDOMYOLYSIS | 2 0.02 88.79 RHABDOMYOSARCOMA | 5 0.05 88.84 RHEUMATIC FEVER | 2 0.02 88.86 RHEUMATOID ARTHRITIS | 388 3.88 92.74 RHINITIS | 2 0.02 92.76 RHINITIS ALLERGIC | 8 0.08 92.84 RHINITIS SEASONAL | 1 0.01 92.85 RHINORRHOEA | 2 0.02 92.87 ROSACEA | 3 0.03 92.90 ROTATOR CUFF REPAIR | 2 0.02 92.92 ROTATOR CUFF SYNDROME | 5 0.05 92.97 ROUTINE HEALTH MAINTENANCE | 1 0.01 92.98 SACRAL PAIN | 1 0.01 92.99 SALIVARY GLAND CANCER | 1 0.01 93.00 SALIVARY HYPERSECRETION | 1 0.01 93.01 SALPINGECTOMY | 2 0.02 93.03 SALPINGITIS | 1 0.01 93.04 SALPINGO-OOPHORECTOMY | 2 0.02 93.06 SALPINGO-OOPHORECTOMY BILATERAL | 1 0.01 93.07 SARCOIDOSIS | 1 0.01 93.08 SARCOMA | 3 0.03 93.11 SCAN BRAIN | 1 0.01 93.12 SCAN PARATHYROID | 1 0.01 93.13 SCHISTOSOMIASIS | 1 0.01 93.14 SCHIZOAFFECTIVE DISORDER | 11 0.11 93.25 SCHIZOPHRENIA | 107 1.07 94.32 SCHIZOPHRENIA, PARANOID TYPE | 7 0.07 94.39 SCHIZOPHRENIA, RESIDUAL TYPE | 1 0.01 94.40 SCHIZOPHRENIA, UNDIFFERENTIATED TYPE | 1 0.01 94.41 SCIATIC NERVE INJURY | 1 0.01 94.42 SCIATICA | 7 0.07 94.49 SCINTIGRAPHY | 1 0.01 94.50 SCLERODERMA | 1 0.01 94.51 SEASONAL ALLERGY | 2 0.02 94.53 SEDATION | 12 0.12 94.65 SENILE OSTEOPOROSIS | 1 0.01 94.66 SENILE PSYCHOSIS | 1 0.01 94.67 SEPSIS | 18 0.18 94.85 SEPTIC SHOCK | 2 0.02 94.87 SEXUAL DYSFUNCTION | 1 0.01 94.88 SHOCK | 1 0.01 94.89 SICK SINUS SYNDROME | 1 0.01 94.90 SICKLE CELL ANAEMIA | 4 0.04 94.94 SICKLE CELL ANAEMIA WITH CRISIS | 2 0.02 94.96 SIDEROBLASTIC ANAEMIA | 1 0.01 94.97 SIMPLE PARTIAL SEIZURES | 5 0.05 95.02 SINUS CONGESTION | 2 0.02 95.04 SINUS DISORDER | 2 0.02 95.06 SINUSITIS | 20 0.20 95.26 SKIN BACTERIAL INFECTION | 2 0.02 95.28 SKIN CANDIDA | 1 0.01 95.29 SKIN DISORDER | 3 0.03 95.32 SKIN GRAFT | 2 0.02 95.34 SKIN INFECTION | 2 0.02 95.36 SKIN LESION | 1 0.01 95.37 SKIN PAPILLOMA | 1 0.01 95.38 SKIN WRINKLING | 3 0.03 95.41 SLEEP DISORDER | 14 0.14 95.55 SLEEP DISORDER THERAPY | 1 0.01 95.56 SMALL CELL CARCINOMA | 10 0.10 95.66 SMALL CELL LUNG CANCER EXTENSIVE STAGE | 4 0.04 95.70 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 39 0.39 96.09 SMALL FOR DATES BABY | 2 0.02 96.11 SMALL INTESTINE CARCINOMA | 2 0.02 96.13 SMOKING CESSATION THERAPY | 5 0.05 96.18 SOCIAL PHOBIA | 5 0.05 96.23 SOCIAL PROBLEM | 1 0.01 96.24 SOMNOLENCE | 4 0.04 96.28 SPINAL ANAESTHESIA | 1 0.01 96.29 SPINAL COLUMN STENOSIS | 2 0.02 96.31 SPINAL CORD COMPRESSION | 1 0.01 96.32 SPINAL CORD DISORDER | 1 0.01 96.33 SPINAL DISORDER | 2 0.02 96.35 SPINAL FRACTURE | 2 0.02 96.37 SPINAL OSTEOARTHRITIS | 1 0.01 96.38 SPINDLE CELL SARCOMA | 1 0.01 96.39 SPONDYLITIS | 7 0.07 96.46 SPONDYLOARTHROPATHY | 1 0.01 96.47 SPONDYLOSIS | 2 0.02 96.49 SPUTUM TEST | 1 0.01 96.50 SQUAMOUS CELL CARCINOMA | 3 0.03 96.53 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 96.54 STAPHYLOCOCCAL INFECTION | 6 0.06 96.60 STAPHYLOCOCCAL SEPSIS | 3 0.03 96.63 STEM CELL TRANSPLANT | 7 0.07 96.70 STENT PLACEMENT | 4 0.04 96.74 STREPTOCOCCAL INFECTION | 1 0.01 96.75 STRESS SYMPTOMS | 6 0.06 96.81 STRESS ULCER | 1 0.01 96.82 STRIDOR | 1 0.01 96.83 STRONGYLOIDIASIS | 4 0.04 96.87 SUBCLAVIAN VEIN THROMBOSIS | 1 0.01 96.88 SUICIDE ATTEMPT | 15 0.15 97.03 SUNBURN | 2 0.02 97.05 SUPRAVENTRICULAR TACHYCARDIA | 8 0.08 97.13 SURGERY | 6 0.06 97.19 SWELLING | 6 0.06 97.25 SYSTEMIC ANTIFUNGAL TREATMENT | 1 0.01 97.26 SYSTEMIC ANTIVIRAL TREATMENT | 5 0.05 97.31 SYSTEMIC CANDIDA | 2 0.02 97.33 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 97.39 SYSTEMIC SCLEROSIS | 3 0.03 97.42 T-CELL LYMPHOMA | 1 0.01 97.43 TACHYARRHYTHMIA | 1 0.01 97.44 TACHYCARDIA | 1 0.01 97.45 TARDIVE DYSKINESIA | 2 0.02 97.47 TEMPORAL ARTERITIS | 1 0.01 97.48 TENDONITIS | 6 0.06 97.54 TERATOMA | 1 0.01 97.55 THALASSAEMIA BETA | 3 0.03 97.58 THROMBOCYTHAEMIA | 2 0.02 97.60 THROMBOCYTOPENIA | 6 0.06 97.66 THROMBOCYTOPENIC PURPURA | 1 0.01 97.67 THROMBOPHLEBITIS | 1 0.01 97.68 THROMBOSIS | 1 0.01 97.69 THROMBOSIS PROPHYLAXIS | 18 0.18 97.87 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 97.88 THYROID CANCER METASTATIC | 1 0.01 97.89 THYROID DISORDER | 6 0.06 97.95 THYROIDECTOMY | 3 0.03 97.98 TINEA CAPITIS | 1 0.01 97.99 TINEA PEDIS | 3 0.03 98.02 TOCOLYSIS | 4 0.04 98.06 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 98.07 TONSILLITIS | 1 0.01 98.08 TOOTH DISCOLOURATION | 1 0.01 98.09 TOOTH DISORDER | 1 0.01 98.10 TOOTH INFECTION | 1 0.01 98.11 TOOTHACHE | 2 0.02 98.13 TOURETTE'S DISORDER | 5 0.05 98.18 TOXOPLASMOSIS | 3 0.03 98.21 TRANSIENT ISCHAEMIC ATTACK | 1 0.01 98.22 TRANSPLANT | 1 0.01 98.23 TRANSPLANT EVALUATION | 22 0.22 98.45 TRANSPLANT REJECTION | 2 0.02 98.47 TREMOR | 4 0.04 98.51 TUBERCULIN TEST | 1 0.01 98.52 TUBERCULIN TEST POSITIVE | 1 0.01 98.53 TUBERCULOSIS | 2 0.02 98.55 TUBERCULOSIS PROPHYLAXIS | 1 0.01 98.56 TUBERCULOUS PLEURISY | 3 0.03 98.59 TYPE IIA HYPERLIPIDAEMIA | 1 0.01 98.60 ULCER | 2 0.02 98.62 ULCER HAEMORRHAGE | 1 0.01 98.63 UNEVALUABLE EVENT | 1 0.01 98.64 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 98.65 UPPER RESPIRATORY TRACT INFECTION | 14 0.14 98.79 UPPER RESPIRATORY TRACT INFLAMMATION | 11 0.11 98.90 URINARY INCONTINENCE | 5 0.05 98.95 URINARY RETENTION | 1 0.01 98.96 URINARY TRACT INFECTION | 29 0.29 99.25 UROSEPSIS | 1 0.01 99.26 URTICARIA | 6 0.06 99.32 UTERINE LEIOMYOMA | 1 0.01 99.33 UTERINE POLYP | 1 0.01 99.34 UVEITIS | 1 0.01 99.35 VAGINITIS ATROPHIC | 2 0.02 99.37 VAGINITIS BACTERIAL | 2 0.02 99.39 VARICES OESOPHAGEAL | 1 0.01 99.40 VARICOSE VEIN | 1 0.01 99.41 VASCULITIS | 7 0.07 99.48 VASCULITIS NECROTISING | 1 0.01 99.49 VENOOCCLUSIVE LIVER DISEASE | 12 0.12 99.61 VENTRICULAR DYSFUNCTION | 1 0.01 99.62 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.63 VENTRICULAR FIBRILLATION | 1 0.01 99.64 VENTRICULAR TACHYCARDIA | 3 0.03 99.67 VERTICAL INFECTION TRANSMISSION | 1 0.01 99.68 VERTIGO | 3 0.03 99.71 VITAMIN SUPPLEMENTATION | 2 0.02 99.73 VOLUME BLOOD DECREASED | 1 0.01 99.74 VOMITING | 5 0.05 99.79 VOMITING IN PREGNANCY | 2 0.02 99.81 WALDENSTROM'S MACROGLOBULINAEMIA | 2 0.02 99.83 WEGENER'S GRANULOMATOSIS | 5 0.05 99.88 WEIGHT CONTROL | 1 0.01 99.89 WEIGHT DECREASED | 3 0.03 99.92 WHEEZING | 2 0.02 99.94 WHITE BLOOD CELL COUNT INCREASED | 3 0.03 99.97 WOUND | 2 0.02 99.99 WOUND INFECTION | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015